Volume 15 Supplement 7
The HPV Prevention and Control Board is supported by in kind contributions and support from the international experts involved and their institutions. To set up the activities and support publication costs, the secretariat obtained unrestricted grants from industry (GlaxoSmithKline Biologicals, Merck). All funds were handled according to the rules of the University of Antwerp. No remuneration for experts or speakers was provided. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.
Antwerp, Belgium13-14 November 2019
Edited by Paolo Bonanni.
For more than a decade human papillomavirus (HPV) vaccine have been implemented in most high-income countries, and more recently also in several low- and middle-income countries. The vaccines are safe and thei...
Citation Impact 2023
Source Normalized Impact per Paper (SNIP): 0.893
SCImago Journal Rank (SJR): 0.475
Usage 2023
Downloads: 640,615
Altmetric mentions: 196